Generation of CTL responses using Kunjin replicon RNA

Immunology and Cell Biology

Volumn 81, Issue 1, 2003, Pages 73-78

  Ward, Scoot M ^a,c   Tindle, Robert W ^a   Khromykh, Alexander A ^a   Gowans, Eric J ^a,b,d  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b BURNET INSTITUTE   (Australia)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d MACFARLANE BURNET INSTITUTE FOR MEDICAL RESEARCH AND PUBLIC HEALTH   (Australia)

Author keywords

CTL; Hepatitis C virus; Kunjin replicon; RNA vaccine

Indexed keywords

POLYRIBONUCLEIC ACID; UNCLASSIFIED DRUG; VIRUS RNA; VIRUS VACCINE;

ANIMAL CELL; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DRUG DELIVERY SYSTEM; HEPATITIS C VIRUS; KUNJIN VIRUS; MOUSE; NONHUMAN; VACCINATION; VIRUS REPLICATION;

ANIMALIA; HEPATITIS C VIRUS; KUNJIN VIRUS; RNA VIRUSES;

EID: 0037324309     PISSN: 08189641     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0818-9641.2002.01137.x     Document Type: Article

References (39)

1. Khromykh AA, Westaway EG. Completion of Kunjin virus RNA sequence and recovery of an infectious RNA transcribed from stably cloned full-length cDNA. J. Virol. 1994; 68: 4580-8.
2. Cola G, Parker MD, Speight G, Byrne ME, Westaway EG. Nucleotide and complete amino acid sequences of Kunjin virus: definitive gene order and characteristics of the virus-specified proteins. J. General Virol. 1988; 69: 1-21.
3. Khromykh AA, Westaway EG. Subgenomic replicons of the flavivirus Kunjin: construction and applications. J. Virol. 1997; 71: 1497-505.
4. Varnavski AN, Khromykh AA. Noncytopathic flavivirus replicon RNA-based system for expression and delivery of heterologous genes. Virology 1999; 255: 366-75.
5. Liljestrom P, Garoff H. A new generation of animal cell expression vectors based on the Semliki Forest virus replicon. Biotechnology (NY) 1991; 9: 1356-61.
6. Xiong C, Levis R, Shen P, Schlesinger S, Rice CM, Huang HV. Sindbis virus: an efficient, broad host range vector for gene expression in animal cells. Science 1989; 243: 1188-91.
7. Pushko P, Parker M, Ludwig GV, Davis NL, Johnston RE, Smith JF. Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo. Virology 1997; 239: 389-401.
8. Percy N, Barclay WS, Sullivan M, Almond JW. A poliovirus replicon containing the chloramphenicol acetyltransferase gene can be used to study the replication and encapsidation of poliovirus RNA. J. Virol. 1992; 66: 5040-6.
9. Agapov EV, Frolov I, Lindenbach BD, Pragai BM, Schlesinger S, Rice CM. Noncytopathic Sindbis virus RNA vectors for heterologous gene expression. Proc. Natl Acad. Sci. USA 1998; 95: 12 989-94.
10. Anraku I, Harvey TJ, Linedale R et al. Kunjin virus replicon vaccine vectors induce protective CD8+ T-cell immunity. J. Virol. 2002; 76: 3791-9.
11. Varnavski AN, Young PR, Khromykh AA. Stable high-level expression of heterologous genes in vitro and in vivo by noncytopathic DNA-based Kunjin virus replicon vectors. J. Virol. 2000; 74: 4394-403.
12. Wolff JA, Malone RW, Williams P et al. Direct gene transfer into mouse muscle in vivo. Science 1990; 247: 1465-8.
13. Martinon F, Krishnan S, Lenzen G et al. Induction of virus-specific cytotoxic T lymphocytes in vivo by liposome-entrapped mRNA. Eur. J. Immunol. 1993; 23: 1719-22.
14. Zhou X, Berglund P, Rhodes G, Parker SE, Jondal M, Liljestrom P. Self-replicating Semliki Forest virus RNA as recombinant vaccine. Vaccine 1994; 12: 1510-14.
15. Ying H, Zaks TZ, Wang RF et al. Cancer therapy using a self-replicating RNA vaccine. Nat. Med. 1999; 5: 823-7.
16. Vignuzzi M, Gerbaud S, van Der Werf S, Escriou N. Naked RNA immunization with replicons derived from poliovirus and Semliki Forest virus genomes for the generation of a cytotoxic T cell response against the influenza A virus nucleoprotein. J. General Virol. 2001; 82: 1737-47.
17. Dubensky TW, Driver DA, Polo JM et al. Sindbis virus DNA-based expression vectors: utility for in vitro and in vivo gene transfer. J. Virol. 1996; 70: 508-19.
18. Berglund P, Smerdou C, Fleeton MN, Tubulekas I, Liljestrom P. Enhancing immune responses using suicidal DNA vaccines. Nat. Biotechnol. 1998; 16: 562-5.
19. Rice CM, Lenches EM, Eddy SR, Shin SJ, Sheets RL, Strauss JH. Nucleotide sequence of yellow fever virus: implications for flavivirus gene expression and evolution. Science 1985; 229: 726-33.
20. Hoerr I, Obst R, Rammensee HG, Jung G. In vivo application of RNA leads to induction of specific cytotoxic T lymphocytes and antibodies. Eur. J. Immunol. 2000; 30: 1-7.
21. Vitiello A, Marchesini D, Furze J, Sherman LA, Chesnut RW. Analysis of the HLA-restricted influenza-specific cytotoxic T lymphocyte response in transgenic mice carrying a chimeric human-mouse class I major histocompatibility complex. J. Exp. Med. 1991; 173: 1007-15.
22. Doan T, Chambers M, Street M et al. Mice expressing the E7 oncogene of HPV16 in epithelium show central tolerance, and evidence of peripheral anergising tolerance, to E7-encoded cytotoxic T-lymphocyte epitopes. Virology 1998; 244: 352-64.
23. Knight RD, Landweber LF. Rhyme or reason: RNA-arginine interactions and the genetic code. Chem. Biol. 1998; 5: R215-20.
24. Warrant RW, Kim SH. Alpha-Helix-double helix interaction shown in the structure of a protamine-transfer RNA complex and a nucleoprotamine model. Nature 1978; 271: 130-5.
25. Cheng WF, Hung CF, Chai CY et al. Enhancement of Sindbis virus self-replicating RNA vaccine potency by linkage of Mycobacterium tuberculosis heat shock protein 70 gene to an antigen gene. J. Immunol. 2001; 166: 6218-26.
26. Sato Y, Roman M, Tighe H et al. Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science 1996; 273: 352-4.
27. Klinman DM, Yamshchikov G, Ishigatsubo Y. Contribution of CpG motifs to the immunogenicity of DNA vaccines. J. Immunol. 1997; 158: 3635-9.
28. Vilcek J, Sen GC. Interferons and other cytokines. In: Fields, BN, Knipe, DM, Howley, PM (eds) Fields Virology, 3rd edn. Philadelphia: Lippincott-Raven, 1996; 275-400.
29. Der SD, Yang YL, Weissmann C, Williams BR. A double-stranded RNA-activated protein kinase-dependent pathway mediating stress-induced apoptosis. Proc. Natl Acad. Sci. USA 1997; 94: 3279-83.
30. Mullbacher A, Lobigs M. Up-regulation of MHC class I by flavivirus-induced peptide translocation into the endoplasmic reticulum. Immunity 1995; 3: 207-14.
31. Shen J, To T, Schrieber SS, King NJ. Early E-selectin, VCAM-1, ICAM-1, and late major histocompatibility complex antigen induction on human endothelial cells by flavivirus and comodulation of adhesion molecule expression by immune cytokines. J. Virol. 1997; 71: 9323-32.
32. Lobigs M, Blanden RV, Mullbacher A. Flavivirus-induced up-regulation of MHC class I antigens; implications for the induction of CD8+ T-cell-mediated autoimmunity. Immunol. Rev. 1996; 152: 5-19.
33. Rehermann B, Chisari FV. Cell mediated immune response to the hepatitis C virus. Curr. Top Microbiol. Immunol. 2000; 242: 299-325.
34. Bergmann CC, Yao Q, Ho CK, Buckwold SL. Flanking residues alter antigenicity and immunogenicity of multi-unit CTL epitopes. J. Immunol. 1996; 157: 3242-9.
35. Hanke T, Schneider J, Gilbert SC, Hill AV, McMichael A. DNA multi-CTL epitope vaccines for HIV and Plasmodium falciparum: immunogenicity in mice. Vaccine 1998; 16: 426-35.
36. Thomson SA, Elliott SL, Sherritt MA et al. Recombinant polyepitope vaccines for the delivery of multiple CD8 cytotoxic T cell epitopes. J. Immunol. 1996; 157: 822-6.
37. Thomson SA, Burrows SR, Misko IS, Moss DJ, Coupar BE, Khanna R. Targeting a polyepitope protein incorporating multiple class II-restricted viral epitopes to the secretory/endocytic pathway facilitates immune recognition by CD4+ cytotoxic T lymphocytes: a novel approach to vaccine design. J. Virol. 1998; 72: 2246-52.
38. Toes RE, Hoeben RC, van der Voort EI et al. Protective anti-tumor immunity induced by vaccination with recombinant adenoviruses encoding multiple tumor-associated cytotoxic T lymphocyte epitopes in a string-of-beads fashion. Proc. Natl Acad. Sci. USA 1997; 94: 14660-5.
39. Whitton JL, Sheng N, Oldstone MB, McKee TA. A 'string-of-beads' vaccine, comprising linked minigenes, confers protection from lethal-dose virus challenge. J. Virol. 1993; 67: 348-52.